baber/WOPTO huggingface dataset:
Patent DK-0501028-T3 (DK)
Inventor: FIEBACK KLAUS DR ING
IPC: B65F1/14
Filed: 1991-12-12
Granted: 1995-06-19
Abstract: To permit treatment, virtually free from external energy, of rotting organic wastes inside a closed container provided with a receiving basket, while utilising natural environmental conditions, in particular solar radiation, the invention proposes to provide a receiving basket having outer wall channels, formed by double walls, utilising the sunshine and intended for forming a natural current while at the same time enabling moisture absorption, for which purpose at least regions of the outer wall of the container are made transparent. <IMAGE>
Patent DK-0492460-T3 (DK)
Inventor: BECHTHOLD HEINZ
IPC: C08J11/06
Filed: 1991-12-19
Granted: 1994-09-26
Abstract: To replace pallets of softwoods or tropical hardwoods, as are required in particular in the concrete industry for producing composite stones, slabs, blocks, kerbstones and the like, it is proposed to produce the pallet substantially from plastics scrap containing thermoplastics by plasticising and extruding the thermoplastics fraction. <IMAGE>
Patent DK-0447237-T3 (DK)
Inventor: HILLUM RICHARD ARTHUR
IPC: H04B1/68
Filed: 1991-03-14
Granted: 1997-05-26
Abstract: In a tone-in-band (TIB) single-sideband-modulated communication system used to communicate digital data:-   a) In order to compensate for variations due, eg, to doppler shift of the pilot tone in the received signal, during the sweep of the frequency of a local oscillator used to tune the receiver, the output of a narrow band filter is monitored for the presence of the expected pilot tone. When the pilot tone appears to be present, the sweep is interrupted and the error rate of the demodulated digital signal is tested, the sweep being resumed if an excessive error rate is encountered. b) In order to counter misreception due to co-channel interference, the pilot tone is offset by a small but detectable amount from that used in a co-channel transmission in preparing the TIB transmission either by using a different frequency split-point or by producing the signal in a slightly different part of the channel.   <IMAGE>
Patent DK-0494501-T3 (DK)
Inventor: COLSON WENDELL B
IPC: E06B9/15
Filed: 1991-11-27
Granted: 1996-10-28
Abstract: A retractable covering devices, in particular, light control window covering (30) including a lobed head (10) rail to prevent creasing and/or skewing of the window covering when rolled up, the head rail (10) having means (20,25) for attaching the window covering (30) which ensures proper alignment of the window covering (30). Also included are a bottom rear rail (40) having an anti-skewing device (48) which comprises a slidable weight (48) for compensating for skewed roll up; a flip-catch device (60) for preventing wrong-way roll up of the window covering; and a top-catch mechanism (62) for preventing both wrong-way roll up and over rotation in the proper roll up direction. <IMAGE>
Patent DK-0521938-T3 (DK)
Inventor: GAYDOUL ANNEGRET
IPC: A47J45/06
Filed: 1991-03-27
Granted: 1996-03-04
Abstract: PCT No. PCT/DE91/00272 Sec. 371 Date Sep. 21, 1992 Sec. 102(e) Date Sep. 21, 1992 PCT Filed Mar. 27, 1991 PCT Pub. No. WO91/14390 PCT Pub. Date Oct. 3, 1991.A steel pan, in particular a forged steel pan, has a shaft (3) which is bent backwards at about mid length. The bent back portion of the shaft forms a handle (4) located above the part not bent back.
Patent DK-0521963-T3 (DK)
Inventor: RIVIER JEAN EDOUARD FREDERIC
IPC: C07K14/655
Filed: 1991-03-21
Granted: 1999-05-10
Abstract: Analogs of CRF, which are based upon rCRF, oCRF, sauvagine and alpha-helical CRF, are disclosed that can be administered to achieve a substantial elevation of ACTH,  beta -endorphin,  beta -lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or an increase in blood pressure over an extended period of time. One analog which has been found to be particularly potent is: H-D-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu- Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-CM L-Nle-Glu-Ile-Ile-NH2. In the analogs of the native 41-residue polypeptides, one or more of the first six N-terminal residues may be deleted and/or the N-terminal alpha-amino group may be acylated by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. These analogs or pharmaceutically or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier, can be administered to mammals, including humans. These analogs may also be used as stimulants to elevate mood and improve memory and learning, as well as diagnostically.
Patent DK-0610179-T3 (DK)
Inventor: LANDO PETER
IPC: A61K47/48
Filed: 1991-07-16
Granted: 1997-03-24
Abstract: A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.
Patent DK-0550783-T3 (DK)
Inventor: TRAITLER HELMUT
IPC: A23K50/40
Filed: 1992-01-09
Granted: 1997-03-17
Abstract: The diesters of 2,3-butanediol and of fatty acids, in particular C16 - C22 fatty acids, are used as energy-intake regulators in animal feeds.
Patent DK-0529031-T3 (DK)
Inventor: MARAGANORE JOHN M
IPC: C07K7/02
Filed: 1992-02-03
Granted: 2000-10-09
Abstract: This invention relates to coating invasive devies with novel biologically active molecules which bind to and inhibit thrombin. These molecules comprise a catalytic site directed moiety (CSDM) of the formula:   <IMAGE>   wherein X is hydrogen or is characterized by a backbone chain consisting of from 1 to 100 atoms; R1 is selected from the group consisting of unsubstituted, mono-substituted, di-substituted and tri-substituted saturated ring structures; R2 is a bond or is characterized by a backbone chain consisting of from 1 to 5 atoms; R3 is a bond or is characterized by a backbone chain consisting of from 1 to 3 atoms; R4 is any amino acid; R5 is any L-amino acid which comprises a guanidinium- or amino-containing side chain group; R6 is a non-amide bond; and Y is characterized by a backbone chain consisting of from 1 to 9 atoms; or the formula:   <IMAGE>   wherein R1' is selected from the group consisting of unsubstituted, mono-substituted, di-substituted and tri-substituted ring structures; R4' is any amino acid comprising a side chain group characterized by the capacity to accept a hydrogen bond at a pH of between about 5.5 and 9.5; and X, R2, R3, R5, R6 and Y are defined as above. Preferred thrombin inhibitors are further characterized by a anion binding exosite associating domain (ABEAM) and a linker portion of between 18  ANGSTROM  and 42  ANGSTROM  in length which connects the Y to the ABEAM.
Patent DK-0581568-T3 (DK)
Inventor: GREGORY JAMES L
IPC: B65D51/16
Filed: 1993-07-27
Granted: 1997-05-20
Abstract: A plastic beverage closure (20) comprising a base wall (21), a peripheral skirt (22) and a plurality of threads on the inner surface of the skirt for engagement with the threads of a container which may be made of glass or plastic. The plastic closure (20) includes a compression molded seal (30) extending about the periphery of the inner surface of the base wall (21) and the juncture of the base wall (21) to the peripheral skirt (22). The closure (20) includes a central axially thickened portion (23); a channel (24) surrounding the thickened portion (23) and extending radially to an annular radially thickened portion (25) on the skirt (22) at the juncture with the base wall (21). A concave surface (29) extends from the base of the channel and merges with the surface of the annular portion. A compression molded liner (30) is provided on the thickened portion (23), channel (24) and concave surface (29) of the closure (20) and defines a planar sealing surface of contact with the end surface of the finish of a container and an arcuate surface for engaging the arcuate surface of a container. In other forms, the closure can be used as a closure for non-beverage products. <IMAGE>
Patent DK-0561759-T3 (DK)
Inventor: HO SA VAN
IPC: B01D71/82
Filed: 1993-03-19
Granted: 2001-09-24
Abstract: An immobilized liquid membrane and a method for selective extraction using same wherein said membrane comprises a hydrophobic polyamphiphilic oligomeric or polymeric liquid supported or immobilized within a microporous support which may be hydrophobic.
Patent DK-0654967-T3 (DK)
Inventor: BENCSITS FRANZ
IPC: A01N37/02
Filed: 1993-07-27
Granted: 1997-07-21
Abstract: The present invention relates to the use of natural or synthetic first runnings coconut fatty acid as an insect-repellent agent which is applied to human or animal skin or to clothing.
Patent DK-0625516-T3 (DK)
Inventor: EMPFIELD JAMES ROY
IPC: A61K31/415
Filed: 1994-03-08
Granted: 1999-06-07
Abstract: Compounds of formula I <CHEM> wherein R<1>, R<2>, R<3>, R<4>, R<5> and A-B have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the treatment of urinery incontinence. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
Patent DK-0620234-T3 (DK)
Inventor: VANHOYE DIDIER
IPC: C08F220/10
Filed: 1994-04-06
Granted: 1998-04-27
Abstract: The process consists in copolymerising a hard monomer such as methyl methacrylate and a flexible monomer such as butyl acrylate, in the presence of methacrylic anhydride. Application to paints.
Patent DK-0663407-T3 (DK)
Inventor: LERCH PETER
IPC: C07K14/775
Filed: 1994-12-28
Granted: 2002-10-28
Abstract: Industrial prodn. of a compsn. (A), contg. reconstituted lipoprotein particles (LPP), comprises first mixing an aq. apolipoprotein (APL) soln. of protein content 1-40 g/l with an aq. lipid(L)-detergent (D) soln., at mole ratio L:D 1:0.5-4 and wt. ratio APL:L 1:1.5-5.The resulting mixt. was incubated at a temp. within 10 degrees C of the phase transition temp. of L in water, then the detergent removed (by exclusion according to mol. size or by using an adsorbent) so that LPP of dia. 5-50 nm and mol.wt. 0.05-1 MD are formed. Without further purificn. steps, over 95% of added protein and over 90% of total L is bound in LPP.Opt. the resulting liq. prod. is lyophilised in presence of a carbohydrate stabiliser.(A) contains 18-22 g/l protein and, at 18-22 degrees C, has turbidity below 40 NTV.
Patent DK-0719276-T3 (DK)
Inventor: BLYE RICHARD P
IPC: A61K31/56
Filed: 1994-09-15
Granted: 1998-08-10
Abstract: The invention presents 17 beta -nitro and 11 beta , 17 beta -dinitro esters of estradiol which are made from 3-acyloxy-17-keto- or 3,17-dihydroxy-1,3,5-estratrienes by processes known in the art. The compounds exhibit estrogenic activity.
Patent DK-0676593-T3 (DK)
Inventor: PLASHKES MACHAEL
IPC: F28F21/06
Filed: 1995-04-07
Granted: 1998-11-23
Abstract: The invention provides a heat exchanger mat, comprising a twin-duct manifold (2) having a duct member comprised of an inlet duct (4) and an outlet duct (6), a tube-socket member fixedly and fluid-tightly attached to the duct member, and a return manifold (8) having a deflector member and a tube-socket member (12) fixedly and fluid-tightly attached to one another. The mat also includes a plurality of tubes (10,10') for circulation of a heat-exchanging liquid medium, each tube (10) fixedly and fluid-tightly joined at one of its ends to the tube-socket member (12) of the twin-duct manifold and at the other one of its ends to the tube-socket member (12) of the return manifold (8). One end of each odd-numbered one of the tubes communicates via at least one aperture with one of the twin ducts, and one end of each even-numbered one of the tubes communicates via at least one other aperture with the other one of the twin ducts, and the other ends of all of the tubes (10) communicate with the return manifold (8). <IMAGE>
Patent DK-0722955-T3 (DK)
Inventor: DAIRE ERICK
IPC: C08F4/60
Filed: 1995-12-21
Granted: 1999-09-13
Abstract: The present invention relates to a process for polymerizing at least one olefin with the aid of a catalyst containing at least one organometallic compound of a transition metal possessing at least one ligand of cyclopentadienyl or substituted cyclopentadienyl type. The polymerization is carried out in gas phase or in suspension in a liquid polymerization medium selected amongst saturated or unsaturated hydrocarbons, in the presence of hydrogen and a polymlerization component selected amongst halogenated hydrocarbons. The combined use of hydrogen and halogenated hydrocarbon in such a polymerization process simultaneously improves the catalyst activity and the molecular weight control of the polymer.
Patent DK-0682944-T3 (DK)
Inventor: BAYOL ALAIN
IPC: A61K47/42
Filed: 1995-05-02
Granted: 1999-10-18
Abstract: Stable, freeze-dried, pharmaceutically acceptable compsns. comprises a protein a buffer, alanine and mannitol. The mannitol/alanine wt. ratio is 0.1-1. Also claimed is a test kit comprising a compsn. as above.
Patent DK-0695454-T3 (DK)
Inventor: TSAI MING-CHANG
IPC: G06F5/01
Filed: 1995-02-13
Granted: 1999-07-05
Abstract: A method and apparatus for implementing a vocoder in an application specific integrated circuit (ASIC) is disclosed. The apparatus contains a DSP core (4) that performs computations in accordance with a reduced instruction set (RISC) architecture. The circuit further comprises a specifically designed slave processor to the DSP core (4) referred to as the minimization processor (6). The feature of the invention is a specifically designed block normalization circuitry. <IMAGE>
Patent DK-0755300-T3 (DK)
Inventor: KONRAD H JONAS
IPC: B01F5/04
Filed: 1995-04-07
Granted: 1999-04-06
Abstract: PCT No. PCT/DE95/00462 Sec. 371 Date Dec. 5, 1996 Sec. 102(e) Date Dec. 5, 1996 PCT Filed Apr. 7, 1995 PCT Pub. No. WO95/27558 PCT Pub. Date Oct. 19, 1995The invention is a device and a method for combining at least two fluid media. The device comprises a flow region (1) which is attached to and/or formed with an opening of a first chamber (2) and which is designed to accommodate the fluid medium coming from the first chamber and to transport it to the outlet (3) of the flow region (1) which is preferably followed by a mixing zone. A second chamber (9) designed to be filled with a second fluid medium is connected to the flow region and/or to the first chamber through at least one first opening element (inlet opening) (11) for diverting part of the first fluid medium from the first into the second chamber. The second chamber is provided with at least one second opening element (second opening) (12) opening into or adjoining the flow region (1) for discharging the second fluid medium displaced into it by the first fluid medium. Several first chambers (2) or second chambers (9) may be provided.
Patent DK-0788512-T3 (DK)
Inventor: HICKEY WILLIAM F
IPC: C07K7/06
Filed: 1995-07-07
Granted: 1999-10-11
Abstract: Proinsulin peptide compounds that modulate an immunological response by T cells of Type I diabetic subjects are disclosed. The proinsulin peptide compounds of the invention are preferably derived from a region of proinsulin that spans the junction between the B chain and C peptide of proinsulin. Pharmaceutical compositions comprising the proinsulin peptide compounds are also disclosed. An immunological response to a proinsulin peptide compound of the invention can be used as an indicator of Type I diabetes in a subject. Accordingly, the invention provides diagnostic assays for Type I diabetes using the proinsulin peptide compounds. Methods for inhibiting the development or progression of Type I diabetes in a subject by administering a proinsulin peptide compound are also disclosed.
Patent DK-0791063-T3 (DK)
Inventor: BAUSSANT THIERRY
IPC: C12R1/22
Filed: 1995-11-07
Granted: 2005-06-06
Abstract: The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of Klebsiella pneumoniae or a protein having at least 80% homology with the P40 protein of Klebsiella pneumoniae. The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.
Patent DK-0797452-T3 (DK)
Inventor: FEARON DOUGLAS THOMAS
IPC: A61K47/48
Filed: 1995-12-06
Granted: 2002-08-19
Abstract: Coupling of C3d molecules or ligands of CD21 or CD19 to an antigen alters the level of immune response to the immunogen upon its administration to an individual. For C3d, the magnitude of the effect is dependent on the number of C3d molecules included in the conjugate. Conveniently, C3d molecules or CD21/CD19 ligands are coupled to an immunogen in fusion polypeptides which may be produced by expression from coding nucleic acid, for instance by culturing host cells containing the nucleic acid. Other means of associating the molecules include chemical cross-linking and co-expression on the surface of a carrier structure. Administration of compositions comprising, in a preferred embodiment, C3d molecules and an immunogen of interest may be used prophylactically (by virtue of the immunological memory induced) or therapeutically. The administration may be for the purpose of raising antibodies to the immunogen. A T-cell response may also be induced.
Patent DK-0784283-T3 (DK)
Inventor: KAMEDA TOSHITADA
IPC: G16H10/60
Filed: 1996-11-27
Granted: 2002-05-13
Abstract: A medical care schedule and record aiding system (201), comprising an inputting device (202) for inputting patient identification date which indicate one of a plurality of patients; an output data generating device (204) for generating output data to be graphically outputted in a format of a table; and an outputting device (205, 206) for graphically outputting the generated output data, said inputting device (202) being constructed to input the medical care data with respect to each patient, each data and each type of the medical care action, said outputting device (205, 206) comprising a displaying device (205) having a picture plane for displaying the generated output data, said inputting device (202) being constructed to specify at least one of an arbitrary date included in a plurality of dates indicated by the output data displayed on the picture plane and an arbitrary type included in a plurality of types indicated by the output data displayed on the picture plane, said output data generating device (204) generating the output data for displaying the medical care data related to said at least one of the date and type specified by said inputting device, in a format different from that of the table, on the basis of the format information corresponding to the different format. <IMAGE>
Patent DK-0920425-T3 (DK)
Inventor: KANE JOHN M
IPC: C07D487/04
Filed: 1996-11-07
Granted: 2003-05-26
Abstract: The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
Patent DK-0807420-T3 (DK)
Inventor: GANEM FRANCK
IPC: A61B17/70
Filed: 1997-05-13
Granted: 2002-11-25
Abstract: The fixing consists of an elongated connecting element (1) with holes for bone anchoring screws (2). Each screw passes through a hole in the connecting element which has a circular recess at its lower end to receive the spherical head (21) of a screw. Each screw hole has an internal thread at its upper end to receive a threaded cap (3) designed to engage with the screw head and lock the screw in the required angular position. The connecting element is in the form of a plate with holes for the screws. Each of the threaded caps has a concave spherical under surface which matches the spherical outer surface of a screw head. Alternatively, the connecting element can have two screw holes linked by a slot which allows it to be adjusted before the screw is tightened. Both screw heads and caps have hexagonal sockets for an instrument to fasten and release them. Their contacting surfaces can have a low friction coating, e.g. of ceramic or diamond-carbon.
Patent DK-0917692-T3 (DK)
Inventor: KROGHRUD HELGE
IPC: B07C5/342
Filed: 1997-07-10
Granted: 2003-01-27
Abstract: PCT No. PCT/NO97/00180 Sec. 371 Date Dec. 1, 1997 Sec. 102(e) Date Dec. 1, 1997 PCT Filed Jul. 10, 1997 PCT Pub. No. WO98/02853 PCT Pub. Date Jan. 22, 1998A device for conveying, lifting and rotating containers (521; 522; 523), (510) are conveyed in lying position past a detector (515) in order to inspect characteristic data regarding the containers, and means (124; 538) which, on the basis of such data, determines how the containers are to be handled. Along a first and a second longitudinal side (510'; 510'') of the conveyor (510) there are provided respectively a first and a second rotatable roll (511, 512), wherein the rolls can be made to rotate with the aid of respective first and second roll driving motors (513, 514) about their longitudinal axis in the same direction of rotation. On co-ordinated movement, the rolls are moveable in the horizontal and optionally the vertical direction relative to the conveyor, whereby the rolls are displaceable to a first position wherein the lie substantially laterally outward relative to the container transport path of the conveyor (510), a second position wherein they are located above the conveyor and displaced towards each so as to be spaced apart at a distance (d) which is smaller than the width of the conveyor, and a third position wherein the rolls are spaced apart at a third distance which is smaller than or equal to said second distance. The detector (515) is a bar code reader located at a distance above the conveyor (510). The rolls (511, 512) are arranged to lift the container up from the conveyor and rotate the container about its longitudinal axis, so that a bar code can be read by the bar code reader (515).
Patent DK-0925294-T3 (DK)
Inventor: MULLER GEORGE W
IPC: A61P31/06
Filed: 1997-07-24
Granted: 2003-04-07
Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF± in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.